Monday, Oct. 5, was probably the first day of 2020 that SARS-CoV-2 had serious competition for science media attention – by another virus. The Nobel Assembly awarded the 2020 Nobel Prize for Physiology or Medicine to Harvey Alter, Michael Houghton and Charles Rice “for the discovery of hepatitis C virus.”
Researchers at the Karolinska Institute have spurred neural stem cells to produce myelin-forming oligodendrocytes, facilitating repair after spinal cord injury.
Researchers at the Feinstein Institutes for Medical Research, the research arm of New York-based Northwell Health, have developed a noninvasive method for targeting stimulation of the vagus nerve. Vagus nerve stimulation (VNS) offers promise for treatment of a wide range of conditions, given the nerve's extensive involvement in regulating many organs, but has been constrained by adverse effects caused by off-target activation of fibers.
Keeping you up to date on recent developments in neurology, including: Social isolation increases anxiety and asymmetry in brain atrophy in AD; Researchers test brain stimulation in zero gravity; Angiotensin inhibitors for AD prevention.
A Taiwanese study has demonstrated that human placental mesenchymal stem cells were therapeutic in hypervirulent Klebsiella pneumonia intra-abdominal infections by secreting IL-1beta to augment neutrophil numbers and functions, while restraining immune responses by other leukocytes.
Keeping you up to date on recent developments in diagnostics, including: Brain imaging reveals signs of childhood trauma; Buyer beware for SARS-CoV-2 antibody detection; Tumor-associated cell cluster signal cancer alert.
Keeping you up to date on recent developments in orthopedics, including: SCS reduces pain and motor symptoms in PD patients; Is rheumatoid arthritis two different diseases?; Lockdown impact: Worsening symptoms for people with bone, joint and muscle pain.
RSS
